drugset / Trial / NCT04363203
VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
RandomizedSingle-groupQuadruple-blindTreatment
Summary
We propose a 3-arm RCT to determine the efficacy of hydroxychloroquine or azithromycin in treating mild to moderate COVID-19 among Veterans in the outpatient setting.
Timeline
- Start
- 2020-04-30
- Primary completion
- 2021-03
- Completion
- 2021-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 250 mg | Oral |
| Comparator | Hydroxychloroquine | Small molecule | 200 mg | Oral |